Clinical trial

Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among…

NCT00407784 · Erasmus Medical Center, Other · Unknown status

Key facts

NCT number NCT00407784
Title Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.
Official title Aldosterone-Renin Ratio to Diagnose Primary Aldosteronism in a Population of Patients With Therapy-Resistant Hypertension: Test Characteristics, Diagnostic Value and Predictive Value for Antihypertensive Treatment. The Dutch ARRAT Study.
Lead sponsor Erasmus Medical Center, Other
Collaborators Dutch Kidney Foundation Pfizer Industry
Status Unknown status
Study type Observational
Conditions Hyperaldosteronism, Hypertension
Intervention type Drug
Interventions eplerenone
Enrollment 500
Start date Jan 1, 2007
Completion Nov 1, 2009
First posted Dec 5, 2006
Last update posted Mar 7, 2007
Countries Netherlands

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies